Learn More About the Roche cobas Liat System
Point-of-care infectious disease testing now includes PCR-based procedures that can be performed in about 20 minutes and with minimal hands-on time.
In just three steps, the Roche cobas™ Liat™ Assays and Analyzer automates the entire nucleic acid test (NAT) process: reagent preparation, target enrichment, inhibitor removal, nucleic acid extraction, amplification, real-time detection, and result interpretation.
- Helps physicians make more informed treatment decisions
- CLIA-waived for influenza A/B, RSV, and Strep A
- More tests under development
|
SARS-CoV-2 + Influenza A/B Multiplex Assay
| ||
|
Influenza A/B + RSV Multiplex Assay
| ||
|
Influenza A/B + RSV Multiplex Assay
| ||
|
Strep A Assay
| ||
|
C. Diff Assay Kit
|
By submitting your data, you agree to our Privacy Policy and will receive emails based on your preferences.
© Thermo Fisher Scientific, Inc. All Rights Reserved.
